IMMUNOGLOBULIN IN ORAL FLUID AS A RELIABLE BIOMARKER FOR ASSESSING THE STATE OF LOCAL IMMUNITY IN THE ORAL CAVITY IN PATIENTS WITH CERVICAL CANCER

Abstract

Cervical cancer (CC) occupies a significant place in the structure of oncological morbidity among women and remains an important medical and social issue. In modern clinical practice, chemotherapy, radiotherapy, and their combinations are widely used in the treatment of this pathology, contributing to improved patient survival. However, these treatment modalities are associated with the development of both systemic and local adverse effects.